{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T01:46:05Z","timestamp":1793929565502,"version":"4.8.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100016389","name":"SENDIMAD","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100016389","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.eprac.2022.11.009","type":"journal-article","created":{"date-parts":[[2022,11,28]],"date-time":"2022-11-28T16:47:30Z","timestamp":1669654050000},"page":"110-118","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Evaluation of Body Composition in Patients With and Without Adrenal Tumors and Without Overt Hypersecretory Syndromes"],"prefix":"10.1016","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0519-0072","authenticated-orcid":false,"given":"Marta","family":"Araujo-Castro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eider","family":"Pascual-Corrales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana M.","family":"Garc\u00eda Cano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Marchan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregori","family":"Casals","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felicia A.","family":"Hanzu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel \u00c1ngel","family":"Gomez-Bermejo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9ctor F.","family":"Escobar Morreale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Valderrabano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.eprac.2022.11.009_bib1","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/S2213-8587(20)30314-4","article-title":"Epidemiology of adrenal tumours in Olmsted County, Minnesota, USA: a population-based cohort study","volume":"8","author":"Ebbehoj","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"2","key":"10.1016\/j.eprac.2022.11.009_bib2","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-16-0467","article-title":"Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors","volume":"175","author":"Fassnacht","year":"2016","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"10.1016\/j.eprac.2022.11.009_bib3","first-page":"408","article-title":"Practical guide on the initial evaluation, follow-up, and treatment of adrenal incidentalomas Adrenal Diseases Group of the Spanish Society of Endocrinology and Nutrition","volume":"67","author":"Araujo-Castro","year":"2020","journal-title":"Endocrinol Diabetes Nutr (Engl Ed)"},{"issue":"12","key":"10.1016\/j.eprac.2022.11.009_bib4","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.4158\/EP-2020-0182","article-title":"Nonfunctioning adrenal incidentalomas are not clinically silent: a longitudinal cohort study","volume":"26","author":"Kim","year":"2020","journal-title":"Endocr Pract"},{"issue":"7","key":"10.1016\/j.eprac.2022.11.009_bib5","first-page":"402","article-title":"Could a nonfunctional adrenal incidentaloma be a risk factor for increased carotid intima-media thickness and metabolic syndrome","volume":"66","author":"Emral","year":"2019","journal-title":"Endocrinol Diabetes Nutr (Engl Ed)"},{"issue":"6","key":"10.1016\/j.eprac.2022.11.009_bib6","doi-asserted-by":"crossref","first-page":"R283","DOI":"10.1530\/EJE-16-0465","article-title":"Therapy of endocrine disease: improvement of cardiovascular risk factors after adrenalectomy in patients with adrenal tumors and subclinical Cushing\u2019s syndrome: a systematic review and meta-analysis","volume":"175","author":"Bancos","year":"2016","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"10.1016\/j.eprac.2022.11.009_bib7","doi-asserted-by":"crossref","first-page":"332","DOI":"10.4103\/ijem.IJEM_52_19","article-title":"Nonfunctioning and subclinical cortisol secreting adrenal incidentalomas and their association with metabolic syndrome: a systematic review","volume":"23","author":"Khan","year":"2019","journal-title":"Indian J Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.eprac.2022.11.009_bib8","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41371-017-0011-4","article-title":"The presence of nonfunctioning adrenal incidentalomas increases arterial hypertension frequency and severity, and is associated with cortisol levels after dexamethasone suppression test","volume":"32","author":"Arruda","year":"2017","journal-title":"J\u00a0Hum Hypertens"},{"issue":"8","key":"10.1016\/j.eprac.2022.11.009_bib9","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1210\/jc.2013-4064","article-title":"Patients with apparently nonfunctioning adrenal incidentalomas may be at increased cardiovascular risk due to excessive cortisol secretion","volume":"99","author":"Androulakis","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.eprac.2022.11.009_bib10","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s12020-020-02544-6","article-title":"Urine steroid profile as a new promising tool for the evaluation of adrenal tumors. Literature review","volume":"72","author":"Araujo-Castro","year":"2021","journal-title":"Endocrine"},{"issue":"1","key":"10.1016\/j.eprac.2022.11.009_bib11","doi-asserted-by":"crossref","first-page":"101488","DOI":"10.1016\/j.beem.2021.101488","article-title":"Steroid profiling in the diagnosis of mild and overt Cushing\u2019s syndrome","volume":"35","author":"Athimulam","year":"2021","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.eprac.2022.11.009_bib12","doi-asserted-by":"crossref","first-page":"5284","DOI":"10.1210\/en.2006-0267","article-title":"Modulation of early human preadipocyte differentiation by glucocorticoids","volume":"147","author":"Tomlinson","year":"2006","journal-title":"Endocrinology"},{"issue":"3","key":"10.1016\/j.eprac.2022.11.009_bib13","doi-asserted-by":"crossref","first-page":"E571","DOI":"10.1152\/ajpendo.00231.2010","article-title":"Pathways regulated by glucocorticoids in omental and subcutaneous human adipose tissues: a microarray study","volume":"300","author":"Lee","year":"2011","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.eprac.2022.11.009_bib14","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1530\/eje.0.1490561","article-title":"Computed tomography assessment of fat distribution in male and female patients with Cushing\u2019s syndrome","volume":"149","author":"Rockall","year":"2003","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"10.1016\/j.eprac.2022.11.009_bib15","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/cen.13512","article-title":"Impact of hypercortisolism on skeletal muscle mass and adipose tissue mass in patients with adrenal adenomas","volume":"88","author":"Delivanis","year":"2018","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"10.1016\/j.eprac.2022.11.009_bib16","doi-asserted-by":"crossref","first-page":"E1260","DOI":"10.1152\/ajpendo.00345.2009","article-title":"Short-term prednisone use antagonizes insulin\u2019s anabolic effect on muscle protein and glucose metabolism in young healthy people","volume":"297","author":"Short","year":"2009","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.eprac.2022.11.009_bib17","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1210\/jc.2012-4276","article-title":"Visceral fat accumulation and postdexamethasone serum cortisol levels in patients with adrenal incidentaloma","volume":"98","author":"Debono","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.eprac.2022.11.009_bib18","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s40618-018-0985-y","article-title":"Evaluation of body composition using dual-energy X-ray absorptiometry in patients with non-functioning adrenal incidentalomas and an intermediate phenotype: is there an association with metabolic syndrome?","volume":"42","author":"Moraes","year":"2019","journal-title":"J\u00a0Endocrinol Invest"},{"issue":"5","key":"10.1016\/j.eprac.2022.11.009_bib19","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1530\/EJE-21-0458","article-title":"Abnormal body composition in patients with adrenal adenomas","volume":"185","author":"Delivanis","year":"2021","journal-title":"Eu J Endocrinol"},{"issue":"5","key":"10.1016\/j.eprac.2022.11.009_bib20","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/cen.13408","article-title":"Autonomous cortisol secretion in adrenal incidentalomas and increased visceral fat accumulation during follow-up","volume":"87","author":"Yener","year":"2017","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"10.1016\/j.eprac.2022.11.009_bib21","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/cen.13902","article-title":"Changes of computed tomography-based body composition after adrenalectomy in patients with endogenous hypercortisolism","volume":"90","author":"Hong","year":"2019","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"10.1016\/j.eprac.2022.11.009_bib22","first-page":"1078","article-title":"Loss of body cell mass in Cushing\u2019s syndrome: effect of treatment","volume":"87","author":"Pirlich","year":"2002","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.eprac.2022.11.009_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12020-019-01888-y","article-title":"Autonomous cortisol secretion in adrenal incidentalomas","volume":"64","author":"Araujo-Castro","year":"2019","journal-title":"Endocrine"},{"issue":"9","key":"10.1016\/j.eprac.2022.11.009_bib24","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.2337\/dc18-su09","article-title":"Updates to the Standards of Medical Care in Diabetes-2018","volume":"41","year":"2018","journal-title":"Diabetes Care"},{"issue":"25","key":"10.1016\/j.eprac.2022.11.009_bib25","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","volume":"106","year":"2002","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.eprac.2022.11.009_bib26","doi-asserted-by":"crossref","first-page":"20539","DOI":"10.1038\/s41598-021-00011-4","article-title":"Diagnostic accuracy of the different hormonal tests used for the diagnosis of autonomous cortisol secretion","volume":"11","author":"Araujo-Castro","year":"2021","journal-title":"Sci Rep"},{"issue":"12","key":"10.1016\/j.eprac.2022.11.009_bib27","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.medcli.2017.12.008","article-title":"The refeeding syndrome. Importance of phosphorus","volume":"150","author":"Araujo Castro","year":"2018","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.eprac.2022.11.009_bib28","series-title":"The Encyclopedia of Mass Spectrometry","first-page":"789","article-title":"GS\/MS steroid profiling: diagnosis of disorders affecting steroid synthesis and metabolism","volume":"8","author":"Shackleton","year":"2006"},{"issue":"1-3","key":"10.1016\/j.eprac.2022.11.009_bib29","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0960-0760(93)90132-G","article-title":"Mass spectrometry in the diagnosis of steroid-related disorders and in hypertension research","volume":"45","author":"Shackleton","year":"1993","journal-title":"J\u00a0Steroid Biochem Mol Biol"},{"key":"10.1016\/j.eprac.2022.11.009_bib30","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jchromb.2014.04.015","article-title":"Microwave-assisted derivatization: application to steroid profiling by gas chromatography\/mass spectrometry","volume":"960","author":"Casals","year":"2014","journal-title":"J\u00a0Chromatogr B Anal Technol Biomed Life Sci"},{"issue":"9","key":"10.1016\/j.eprac.2022.11.009_bib31","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.clinbiochem.2013.03.001","article-title":"Gas chromatography-mass spectrometry profiling of steroids in urine of patients with acute intermittent porphyria","volume":"46","author":"Casals","year":"2013","journal-title":"Clin Biochem"},{"issue":"2","key":"10.1016\/j.eprac.2022.11.009_bib32","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J\u00a0Biomed Inform"},{"key":"10.1016\/j.eprac.2022.11.009_bib33","doi-asserted-by":"crossref","first-page":"103208","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: building an international community of software platform partners","volume":"95","author":"Harris","year":"2019","journal-title":"J\u00a0Biomed Inform"},{"issue":"4","key":"10.1016\/j.eprac.2022.11.009_bib34","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1080\/07435809609043773","article-title":"Adrenal incidentalomas: a manifestation of the metabolic syndrome?","volume":"22","author":"Reincke","year":"1996","journal-title":"Endocr Res"},{"issue":"14","key":"10.1016\/j.eprac.2022.11.009_bib35","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/j.steroids.2011.09.010","article-title":"Increased urinary glucocorticoid metabolites are associated with metabolic syndrome, hypoadiponectinemia, insulin resistance and \u03b2 cell dysfunction","volume":"76","author":"Baudrand","year":"2011","journal-title":"Steroids"},{"issue":"3","key":"10.1016\/j.eprac.2022.11.009_bib36","first-page":"141","article-title":"Glucocorticoids and 11beta-hydroxysteroid dehydrogenase type 1 in obesity and the metabolic syndrome","volume":"32","author":"Stimson","year":"2007","journal-title":"Minerva Endocrinol"},{"key":"10.1016\/j.eprac.2022.11.009_bib37","article-title":"Characterisation of the urinary steroid profile of patients with nonfunctioning adrenal incidentalomas: a matched controlled cross-sectional study","author":"Araujo-Castro","year":"2022","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"10.1016\/j.eprac.2022.11.009_bib38","doi-asserted-by":"crossref","first-page":"101494","DOI":"10.1016\/j.beem.2021.101494","article-title":"Cardiovascular complications of mild autonomous cortisol secretion","volume":"35","author":"Aresta","year":"2021","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.eprac.2022.11.009_bib39","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.clnesp.2018.08.013","article-title":"Comparison of segmental body composition estimated by bioelectrical impedance analysis and dual-energy X-ray absorptiometry","volume":"28","author":"Wingo","year":"2018","journal-title":"Clin Nutr ESPEN"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X22008710?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X22008710?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,27]],"date-time":"2024-07-27T10:05:13Z","timestamp":1722074713000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X22008710"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["S1530891X22008710"],"URL":"https:\/\/doi.org\/10.1016\/j.eprac.2022.11.009","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of Body Composition in Patients With and Without Adrenal Tumors and Without Overt Hypersecretory Syndromes","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eprac.2022.11.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 AACE. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}